Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CODX
12201
CALL
Co-Diagnostics
CODX
$5.56M
| $28.3K | ﹤0.01% |
5,587
+4,214
| +307% | +$45.9K |
|
|
SGRP
12202
DELISTED
SPAR Group
SGRP
| $28.1K | ﹤0.01% |
35,527
+21,884
| +160% | +$21K |
|
|
PPBT
12203
Purple Biotech
PPBT
$1.4M
| $28.1K | ﹤0.01% |
4,274
+148
| +4% | +$1.07K |
|
|
TUYA
12204
CALL
Tuya Inc
TUYA
$1.07B
| $28.1K | ﹤0.01% |
+13,300
| New | +$30.3K |
|
12205
Traws Pharma
TRAW
$8.43M
| $28K | ﹤0.01% |
+24,819
| New | +$55.2K |
|
|
LHSW
12206
Lianhe Sowell International Group
LHSW
$8.35M
| $28K | ﹤0.01% |
3,426
+2,162
| +171% | +$53K |
|
12207
Marygold Companies
MGLD
$44.4M
| $27.9K | ﹤0.01% |
31,597
+8,735
| +38% | +$8.74K |
|
|
DDL
12208
CALL
Dingdong
DDL
$509M
| $27.9K | ﹤0.01% |
11,200
-900
| -7% | -$1.79K |
|
12209
Bluejay Diagnostics
BJDX
$1.03M
| $27.9K | ﹤0.01% |
+10,449
| New | +$68.6K |
|
12210
Polar Power
POLA
$6.84M
| $27.8K | ﹤0.01% |
+16,661
| New | +$51.4K |
|
|
JCTC
12211
Jewett-Cameron Trading
JCTC
$9.47M
| $27.8K | ﹤0.01% |
12,365
-10,192
| -45% | -$28K |
|
|
ICG
12212
Intchains Group
ICG
$51.6M
| $27.7K | ﹤0.01% |
+15,468
| New | +$23.9K |
|
|
AIOS
12213
AIOS Tech
AIOS
$38.2M
| $27.6K | ﹤0.01% |
1,292
+644
| +99% | +$43.6K |
|
12214
TELA Bio
TELA
$40.6M
| $27.6K | ﹤0.01% |
23,382
-11,899
| -34% | -$15.1K |
|
12215
CALL
Douglas Elliman
DOUG
$160M
| $27.5K | ﹤0.01% |
+11,600
| New | +$29.8K |
|
|
SACH
12216
CALL
Sachem Capital Corp
SACH
$40M
| $27.2K | ﹤0.01% |
+26,200
| New | +$28K |
|
12217
PUT
Ovid Therapeutics
OVID
$474M
| $27.2K | ﹤0.01% |
16,700
-45,800
| -73% | -$70.5K |
|
|
MOGU
12218
MOGU Inc
MOGU
$16.7M
| $26.9K | ﹤0.01% |
+12,612
| New | +$35.3K |
|
12219
Battalion Oil
BATL
$29.7M
| $26.7K | ﹤0.01% |
23,649
-11,524
| -33% | -$13.2K |
|
|
TDTH
12220
Trident Digital Tech Holdings Ltd Class B Ordinary Shares
TDTH
$2.88B
| $26.7K | ﹤0.01% |
+2,967
| New | +$56.3K |
|
12221
PUT
Century Casinos
CNTY
$34.3M
| $26.6K | ﹤0.01% |
+20,000
| New | +$35.7K |
|
|
PMAX
12222
Powell Max Ltd
PMAX
$2.68M
| $26.6K | ﹤0.01% |
+1,470
| New | +$35.5K |
|
12223
Golden Sun Technology Group
GSUN
$5.36M
| $26.6K | ﹤0.01% |
+23,299
| New | +$42.9K |
|
|
COOT
12224
Australian Oilseeds Holdings
COOT
$12.3M
| $26.5K | ﹤0.01% |
51,469
+12,940
| +34% | +$13.7K |
|
12225
CALL
Black Diamond Therapeutics
BDTX
$102M
| $26.5K | ﹤0.01% |
+10,900
| New | +$38.6K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.